cystic fibrosis

October 12, 2018October 12, 2018

Synthetic Antimicrobial Peptide Can Destroy Biofilms in CF Patients, Study Reports

cystic fibrosis, News

A therapy that involves a synthetic cationic antimicrobial peptide (CAP) can decrease Pseudomonas aeruginosa biofilm formation alone or in combination with another antimicrobial agent called tobramycin. Cystic fibrosis (CF) patients are susceptible ... Read more

October 10, 2018October 10, 2018

Bicarbonate Eyed as Weapon to Combat 2 Most Prevalent Bacteria in CF

cystic fibrosis, News

Adding bicarbonate, a salt, to the culture medium of Pseudomonas aeruginosa and Staphylococcus aureus, two of the most common bacteria underlying lung infections in people with cystic fibrosis (CF), impairs ... Read more

October 9, 2018October 9, 2018

Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments

cystic fibrosis

Half a year has gone by since disgraced pharma executive Martin Shkreli was sentenced to seven years in federal prison for securities and wire fraud while heading San Diego-based ... Read more

October 9, 2018October 9, 2018

New Approach Against Antibiotic-resistant Bacteria in CF Patients Shows Promise in Phase 1 Trial

cystic fibrosis, News

Researchers may have found a new way of treating antibiotic-resistant bacterial infections, specifically Pseudomonas aeruginosa, in the airways of patients with cystic fibrosis (CF), a study shows. In a ... Read more

October 8, 2018October 8, 2018

Nutritional Well-Being After Transplant Measure of Likely Lung Health, Study Finds

cystic fibrosis, News

The nutritional status of cystic fibrosis (CF) patients after a lung transplant — as assessed by body composition — is a strong predictor of lung function post-surgery, a study shows. The ... Read more

October 4, 2018October 4, 2018

Antibiotics Make Bacteria More Resistant by Lowering Microbial Diversity in Lungs, Study Suggests

cystic fibrosis, News

Antibiotics lessen the diversity of microbes in the lungs of cystic fibrosis (CF) patients, and make these people more susceptible to infections with bacteria that are highly resistant to ... Read more

October 3, 2018October 3, 2018

Agreement Readies Denmark, Austria for Approval of Vertex CF Therapies

cystic fibrosis, News

Vertex Pharmaceuticals has entered a partnership with the Danish pharmaceutical organization Amgros to one day make Vertex’s cystic fibrosis (CF) therapies available for Danish patients. The collaboration was made through ... Read more

October 2, 2018October 2, 2018

Decibel Obtains Exclusive License for ORC-13661 for Prevention of Antibiotic-related Ototoxicity

cystic fibrosis, News

Decibel Therapeutics received worldwide, exclusive rights to develop and commercialize ORC-13661, Oricula Therapeutics’ investigational treatment to prevent hearing loss and balance disorders in patients taking high doses of aminoglycoside ... Read more

October 1, 2018October 1, 2018

MS1819-SD Shows Positive Results for Exocrine Pancreatic Insufficiency in Phase 2a Trial

cystic fibrosis, News

AzurRx BioPharma, in partnership with Mayoly Spindler, announced that a recent Phase 2a clinical trial testing MS1819-SD as a potential treatment for exocrine pancreatic insufficiency (EPI) achieved its goals, namely ... Read more

September 28, 2018October 2, 2018

#NACFC — Sound Pharmaceuticals to Present Preliminary Data on Ototoxicity Study

cystic fibrosis, News

Sound Pharmaceuticals (SPI) will present data on the incidence and severity of ototoxicity in cystic fibrosis (CF) patients who received tobramycin for the treatment of acute pulmonary exacerbations. The ... Read more

Pin It on Pinterest